S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:SLP

Simulations Plus Stock Forecast, Price & News

$66.46
+4.21 (+6.76 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$61.57
Now: $66.46
$67.00
50-Day Range
$62.25
MA: $77.36
$89.52
52-Week Range
$26.00
Now: $66.46
$90.92
Volume404,284 shs
Average Volume221,790 shs
Market Capitalization$1.33 billion
P/E Ratio130.32
Dividend Yield0.36%
Beta-0.07
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.
Simulations Plus logo

Headlines

What We Learned About Simulations Plus' (NASDAQ:SLP) CEO Pay
February 22, 2021 |  finance.yahoo.com
Simulations Plus Releases GastroPlus® Version 9.8.1
February 9, 2021 |  finance.yahoo.com
Teladoc Reaches 80-Plus Relative Strength Rating Benchmark
January 26, 2021 |  finance.yahoo.com
Recap: Simulations Plus Q1 Earnings
January 11, 2021 |  benzinga.com
Earnings Outlook For Simulations Plus
January 8, 2021 |  benzinga.com
SLP Jan 2021 45.000 call
December 23, 2020 |  uk.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryN/A
Current SymbolNASDAQ:SLP
CUSIPN/A
Phone661-723-7723
Employees129
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$41.59 million
Cash Flow$0.70 per share
Book Value$7.92 per share

Profitability

Net Income$9.33 million

Miscellaneous

Market Cap$1.33 billion
Next Earnings Date4/8/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.03 out of 5 stars

Computer And Technology Sector

91st out of 1,526 stocks

Computer Integrated Systems Design Industry

8th out of 53 stocks

Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -
$66.46
+4.21 (+6.76 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SLP News and Ratings via Email

Sign-up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Simulations Plus (NASDAQ:SLP) Frequently Asked Questions

Is Simulations Plus a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Simulations Plus stock.
View analyst ratings for Simulations Plus
or view top-rated stocks.

What stocks does MarketBeat like better than Simulations Plus?

Wall Street analysts have given Simulations Plus a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Simulations Plus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Simulations Plus' next earnings date?

Simulations Plus is scheduled to release its next quarterly earnings announcement on Thursday, April 8th 2021.
View our earnings forecast for Simulations Plus
.

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) issued its quarterly earnings results on Sunday, January, 10th. The technology company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.11 by $0.01. The technology company earned $10.70 million during the quarter, compared to the consensus estimate of $10.56 million. Simulations Plus had a trailing twelve-month return on equity of 10.65% and a net margin of 22.74%.
View Simulations Plus' earnings history
.

How has Simulations Plus' stock price been impacted by COVID-19?

Simulations Plus' stock was trading at $30.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SLP stock has increased by 120.1% and is now trading at $66.46.
View which stocks have been most impacted by COVID-19
.

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus announced a quarterly dividend on Monday, January 11th. Stockholders of record on Monday, January 25th will be paid a dividend of $0.06 per share on Monday, February 1st. This represents a $0.24 annualized dividend and a yield of 0.36%. The ex-dividend date is Friday, January 22nd.
View Simulations Plus' dividend history
.

Is Simulations Plus a good dividend stock?

Simulations Plus pays an annual dividend of $0.24 per share and currently has a dividend yield of 0.36%. Simulations Plus does not yet have a strock track record of dividend growth. The dividend payout ratio of Simulations Plus is 42.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Simulations Plus will have a dividend payout ratio of 35.29% next year. This indicates that Simulations Plus will be able to sustain or increase its dividend.
View Simulations Plus' dividend history.

What price target have analysts set for SLP?

4 analysts have issued 12 month target prices for Simulations Plus' shares. Their forecasts range from $76.00 to $95.00. On average, they anticipate Simulations Plus' stock price to reach $84.25 in the next year. This suggests a possible upside of 26.8% from the stock's current price.
View analysts' price targets for Simulations Plus
or view top-rated stocks among Wall Street analysts.

Who are Simulations Plus' key executives?

Simulations Plus' management team includes the following people:
  • Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 76, Pay $57.5k)
  • Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 61, Pay $506k)
  • Mr. John Anthony DiBella, Pres of the Lancaster Division (Age 41, Pay $293.04k)
  • Mr. John R. Kneisel CPA, CPA, Advisor (Age 63, Pay $895.41k)
  • Mr. William Frederick, CFO & Sec. (Age 57)
  • Dr. Alexander Berg, VP of Operations
  • Ms. Viera Lukacova Ph.D., Chief Scientist
  • Ms. Arlene Padron, Marketing Director
  • Nguyen Nguyen, VP of HR
  • Dr. Michael B. Bolger Ph.D., Founding Scientist

Who are some of Simulations Plus' key competitors?

What other stocks do shareholders of Simulations Plus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include Advanced Micro Devices (AMD), Cisco Systems (CSCO), Gilead Sciences (GILD), QUALCOMM (QCOM), NVIDIA (NVDA), Verizon Communications (VZ), CVS Health (CVS), Enterprise Products Partners (EPD), AbbVie (ABBV) and Pfizer (PFE).

What is Simulations Plus' stock symbol?

Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."

Who are Simulations Plus' major shareholders?

Simulations Plus' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.40%), Dimensional Fund Advisors LP (2.44%), Russell Investments Group Ltd. (1.65%), Royce & Associates LP (1.61%), Conestoga Capital Advisors LLC (1.19%) and William Blair Investment Management LLC (1.06%). Company insiders that own Simulations Plus stock include David L Ralph, John Anthony Dibella II, John Kenneth Paglia, Lisa Lavange, Shawn Oconnor and Walter S Woltosz.
View institutional ownership trends for Simulations Plus
.

Which institutional investors are selling Simulations Plus stock?

SLP stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Dimensional Fund Advisors LP, William Blair Investment Management LLC, Renaissance Technologies LLC, Wells Fargo & Company MN, The Manufacturers Life Insurance Company , Aviva PLC, and Calamos Advisors LLC. Company insiders that have sold Simulations Plus company stock in the last year include David L Ralph, John Anthony Dibella II, John Kenneth Paglia, Lisa Lavange, Shawn Oconnor, and Walter S Woltosz.
View insider buying and selling activity for Simulations Plus
or view top insider-selling stocks.

Which institutional investors are buying Simulations Plus stock?

SLP stock was acquired by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, BlackRock Inc., Ziegler Capital Management LLC, InTrack Investment Management Inc, Russell Investments Group Ltd., First Trust Advisors LP, Royce & Associates LP, and Janus Henderson Group PLC.
View insider buying and selling activity for Simulations Plus
or or view top insider-buying stocks.

How do I buy shares of Simulations Plus?

Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Simulations Plus' stock price today?

One share of SLP stock can currently be purchased for approximately $66.46.

How much money does Simulations Plus make?

Simulations Plus has a market capitalization of $1.33 billion and generates $41.59 million in revenue each year. The technology company earns $9.33 million in net income (profit) each year or $0.56 on an earnings per share basis.

How many employees does Simulations Plus have?

Simulations Plus employs 129 workers across the globe.

What is Simulations Plus' official website?

The official website for Simulations Plus is www.simulations-plus.com.

Where are Simulations Plus' headquarters?

Simulations Plus is headquartered at 42505 10TH STREET WEST, LANCASTER CA, 93534.

How can I contact Simulations Plus?

Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.